These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34578354)

  • 1. SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Sapkal G; Lole K; Gupta N
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
    Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
    Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model.
    Yadav P; Mohandas S; Sarkale P; Nyayanit D; Shete A; Sahay R; Potdar V; Baradkar S; Gupta N; Sapkal G; Abraham P; Panda S; Bhargava B
    J Infect Public Health; 2022 Feb; 15(2):164-171. PubMed ID: 34959053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF
    Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters.
    Mohandas S; Yadav PD; Nyayanit D; Shete A; Sarkale P; Hundekar S; Kumar S; Lole K
    Vector Borne Zoonotic Dis; 2021 Aug; 21(8):638-641. PubMed ID: 34197265
    [No Abstract]   [Full Text] [Related]  

  • 9. The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
    Stauft CB; Lien CZ; Selvaraj P; Liu S; Wang TT
    Virology; 2021 Apr; 556():96-100. PubMed ID: 33556653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
    Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook MG; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
    PLoS Pathog; 2022 Feb; 18(2):e1009914. PubMed ID: 35143587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
    Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
    mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
    Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
    Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection.
    Nuñez IA; Lien CZ; Selvaraj P; Stauft CB; Liu S; Starost MF; Wang TT
    mSphere; 2021 Jun; 6(3):e0050721. PubMed ID: 34133199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
    J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
    Braun MR; Martinez CI; Dora EG; Showalter LJ; Mercedes AR; Tucker SN
    Front Immunol; 2023; 14():1086035. PubMed ID: 36911687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.